OBJECTIVE: Enhanced N-methyl-D-aspartate (NMDA) receptor function associated with a positive family history of alcoholism (FHP) has been hypothesized to contribute to the heritable risk for alcoholism. The objective of this study was to evaluate the relationship of alcoholism family history, NMDA receptor function, and cortical information processing by testing acute effects of the NMDA receptor antagonist memantine on event-related potential (ERP). METHOD: Twenty-two healthy FHP and 20 healthy family history-negative (FHN; no alcoholic relatives) subjects were administered placebo or 40 mg of memantine under double-blind counterbalanced conditions on two separate occasions. Electroencephalogram data were collected from eight channels with eyes open during an auditory oddball discrimination task. We evaluated P3b amplitude, total theta, alpha activity, and fractal dimension from ERP trials. RESULTS: FHP and FHN subjects did not differ in P3b amplitude. A significant Group × Drug interaction was observed in theta, alpha activity, and fractal dimension at the parietal and occipital sites. FHP individuals exhibited significantly higher fractal dimension and lower theta and alpha activity after placebo relative to FHN subjects. Following memantine administration, theta activity decreased in both groups but more markedly for FHN individuals. Alpha activity decreased for FHN subjects and increased for FHP individuals, whereas the fractal dimension decreased for FHP subjects and increased for FHN subjects after memantine. CONCLUSIONS: A plausible interpretation of these results is that FHP individuals may have altered NMDA receptor function compared with FHN individuals. These findings provide additional evidence of differences in the regulation of NMDA receptor function between FHP and FHN individuals.
RCT Entities:
OBJECTIVE: Enhanced N-methyl-D-aspartate (NMDA) receptor function associated with a positive family history of alcoholism (FHP) has been hypothesized to contribute to the heritable risk for alcoholism. The objective of this study was to evaluate the relationship of alcoholism family history, NMDA receptor function, and cortical information processing by testing acute effects of the NMDA receptor antagonist memantine on event-related potential (ERP). METHOD: Twenty-two healthy FHP and 20 healthy family history-negative (FHN; no alcoholic relatives) subjects were administered placebo or 40 mg of memantine under double-blind counterbalanced conditions on two separate occasions. Electroencephalogram data were collected from eight channels with eyes open during an auditory oddball discrimination task. We evaluated P3b amplitude, total theta, alpha activity, and fractal dimension from ERP trials. RESULTS: FHP and FHN subjects did not differ in P3b amplitude. A significant Group × Drug interaction was observed in theta, alpha activity, and fractal dimension at the parietal and occipital sites. FHP individuals exhibited significantly higher fractal dimension and lower theta and alpha activity after placebo relative to FHN subjects. Following memantine administration, theta activity decreased in both groups but more markedly for FHN individuals. Alpha activity decreased for FHN subjects and increased for FHP individuals, whereas the fractal dimension decreased for FHP subjects and increased for FHN subjects after memantine. CONCLUSIONS: A plausible interpretation of these results is that FHP individuals may have altered NMDA receptor function compared with FHN individuals. These findings provide additional evidence of differences in the regulation of NMDA receptor function between FHP and FHN individuals.
Authors: M Breakspear; J R Terry; K J Friston; A W F Harris; L M Williams; K Brown; J Brennan; E Gordon Journal: Neuroimage Date: 2003-09 Impact factor: 6.556
Authors: Ajayan Padmanabhapillai; Yongqiang Tang; Mohini Ranganathan; Madhavi Rangaswamy; Kevin A Jones; David B Chorlian; Chella Kamarajan; Arthur Stimus; Samuel Kuperman; John Rohrbaugh; Sean J O'Connor; Lance O Bauer; Marc A Schuckit; Henri Begleiter; Bernice Porjesz Journal: Int J Psychophysiol Date: 2006-08-02 Impact factor: 2.997
Authors: Handan Gunduz-Bruce; Robert M G Reinhart; Brian J Roach; Ralitza Gueorguieva; Stephen Oliver; Deepak C D'Souza; Judith M Ford; John H Krystal; Daniel H Mathalon Journal: Biol Psychiatry Date: 2011-10-29 Impact factor: 13.382
Authors: Sudha Suresh; Bernice Porjesz; David B Chorlian; Keewhan Choi; Kevin A Jones; Kongming Wang; Arthur Stimus; Henri Begleiter Journal: Alcohol Clin Exp Res Date: 2003-07 Impact factor: 3.455
Authors: D Dickerson; B Pittman; E Ralevski; A Perrino; D Limoncelli; J Edgecombe; G Acampora; J H Krystal; I Petrakis Journal: J Psychopharmacol Date: 2008-11-21 Impact factor: 4.153
Authors: Suchitra Krishnan-Sarin; Stephanie S O'Malley; Nicholas Franco; Dana A Cavallo; Meghan Morean; Julia Shi; Brian Pittman; John H Krystal Journal: Alcohol Clin Exp Res Date: 2015-02-09 Impact factor: 3.455
Authors: Krishna T Patel; Michael C Stevens; Amanda Dunlap; Alana Gallagher; Stephanie S O'Malley; Kelly DeMartini; Marc N Potenza; John H Krystal; Godfrey D Pearlson Journal: Neuropsychopharmacology Date: 2021-09-02 Impact factor: 8.294
Authors: Fenne Margreeth Smits; Camillo Porcaro; Carlo Cottone; Andrea Cancelli; Paolo Maria Rossini; Franca Tecchio Journal: PLoS One Date: 2016-02-12 Impact factor: 3.240